Cowealth Medical China Co.Ltd.
Cowealth Medical China Co.,Ltd. operates as a medical company in China. It offers management services for in-vitro diagnostic reagents and consumables; platform for decision-making and analysis, commercialization of achievements in medical science and technology; a multi-channel coaxial time audio video imaging platform; and an AI-assisted system for clinical diagnosis. The company was founded in… Read more
Cowealth Medical China Co.Ltd. (603122) - Total Assets
Latest total assets as of June 2025: CN¥1.60 Billion CNY
Based on the latest financial reports, Cowealth Medical China Co.Ltd. (603122) holds total assets worth CN¥1.60 Billion CNY as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Cowealth Medical China Co.Ltd. - Total Assets Trend (2019–2024)
This chart illustrates how Cowealth Medical China Co.Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Cowealth Medical China Co.Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
Cowealth Medical China Co.Ltd.'s total assets of CN¥1.60 Billion consist of 86.4% current assets and 13.6% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 17.5% |
| Accounts Receivable | CN¥738.47 Million | 49.4% |
| Inventory | CN¥201.88 Million | 13.5% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥7.48 Million | 0.5% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Cowealth Medical China Co.Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cowealth Medical China Co.Ltd.'s current assets represent 86.4% of total assets in 2024, a decrease from 87.2% in 2019.
- Cash Position: Cash and equivalents constituted 17.5% of total assets in 2024, up from 5.0% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 49.4% of total assets.
Cowealth Medical China Co.Ltd. Competitors by Total Assets
Key competitors of Cowealth Medical China Co.Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Cowealth Medical China Co.Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Cowealth Medical China Co.Ltd. generates 0.63x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Cowealth Medical China Co.Ltd. generates $ 1.85 in net profit.
Cowealth Medical China Co.Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.82 | 4.35 | 4.78 |
| Quick Ratio | 2.41 | 3.66 | 4.16 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥881.38 Million | CN¥ 961.28 Million | CN¥ 1.05 Billion |
Cowealth Medical China Co.Ltd. - Advanced Valuation Insights
This section examines the relationship between Cowealth Medical China Co.Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.06 |
| Latest Market Cap to Assets Ratio | 0.26 |
| Asset Growth Rate (YoY) | 2.2% |
| Total Assets | CN¥1.49 Billion |
| Market Capitalization | $390.05 Million USD |
Valuation Analysis
Below Book Valuation: The market values Cowealth Medical China Co.Ltd.'s assets below their book value (0.26 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Cowealth Medical China Co.Ltd.'s assets grew by 2.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Cowealth Medical China Co.Ltd. (2019–2024)
The table below shows the annual total assets of Cowealth Medical China Co.Ltd. from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.49 Billion | +2.24% |
| 2023-12-31 | CN¥1.46 Billion | -6.26% |
| 2022-12-31 | CN¥1.56 Billion | +39.13% |
| 2021-12-31 | CN¥1.12 Billion | +0.77% |
| 2020-12-31 | CN¥1.11 Billion | -1.60% |
| 2019-12-31 | CN¥1.13 Billion | -- |